CARDIOVASCULAR ENGINEERING

CARDIOVASCULAR
ENGINEERING

Official Publication of the World Artificial Organ, Immunology and Transplantation Society (WAITS)

Volume 10, 2005, No 1


Clinical Experience with a New “Minimally Invasive Circulatory Support System” (CardioVention CORx-System) for Coronary Artery Bypass
J. Wippermann, J. M. Albes, M. Kaluza, H. Brandes, M. Hartrumpf, Th. Wahlers


Objective: Cardiopulmonary bypass (CPB) is known to cause part of the postoperative systemic inflammatory reaction and hemodilution. In order to reduce these problems a novel technique based on a single disposable, compact arterio-venous loop with an integrated centrifugal blood pump and oxygenating, air removal and gross filtration capabilities (CardioVention GmbH, Seevetal, Germany) has been developed. The applicability of this system and patients outcome was investigated in our clinic.
Methods: Five consecutive patients (59,6 + 8,3 y) with good left ventricular function (ejection fraction > 50 %) underwent coronary bypass surgery with the new CardioVention CORx system. Specific evaluation of handling, priming volume, hematocrite- and hemoglobine values were performed. Serial blood samples were taken prior to the onset, after initiation, before weaning of the CPB and 6 hours postoperatively.
Results: The peri- and postoperative course of all patients was completely uneventful.
Postoperatively stay on ICU was 16,6 + 1,7 hours. Priming volume in all cases was 820 ml. On pump the minimun hematocrite level was 37,2 + 3,2 %. The mean hemoglobine level after surgery was 6,3 + 1,5 mmol/l versus 9,1 + 0,7 mmol/l. No transfusion of blood or blood- products were needed in any patient.
Conclusions: In our initial experience the CardioVention CORx system is suitable to maintain total extracorporal circulation with a 50% reduction of the priming volume. The likewise reduced foreign surface of 25 % compared to standard CPB may be accompanied by less inflammatory response.

(CVE. 2005; 10 (1): 13-17)

Key words: Low prime volume circuit, Cardiovention, hemodilution, foreign surface-reduction


Jens Wippermann, M.D.
Cardiothoracic and Vascular Sugery
University Hospital Jena
Bachstr. 18
D-07743 Jena
Germany
E- mail: Jens.Wippermann@med.uni-jena.de



PSP-Logo
PABST SCIENCE PUBLISHERS
Lengerich, Berlin, Riga, Rom, Wien, Zagreb